THE FDA is urging drug
manufacturers of combination
drugs which contain
acetaminophen to limit the
amount of the ingredient to no
more than 325mgs per tablet/
capsule.
It is hoped the move will
minimise the potential risk of liver
damage to users of pain and fever
drugs.
The FDA has also declared
manufacturers must update
product labels to reflect
acetaminophen’s potential to
cause severe liver damage.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jan 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.